Loop-Mediated Isothermal Amplification of Trypanosoma cruzi DNA for Point-of-Care Follow-Up of Anti-Parasitic Treatment of Chagas Disease

• Main Authors: Barcan, L.A (Author), Besuschio, S.A (Author), de Noya, B.A (Author), Fernández, M. (Author), García Cáceres, L.J (Author), Giorgio, P. (Author), Liu, Y.E (Author), Longhi, S.A (Author), Markham, C. (Author), Muñoz-Calderón, A.A (Author), Schijman, A.G (Author), Wong, S. (Author)
• Format: Article
• Language: English
• Published: MDPI 2022
• Subjects: Chagas disease reactivation; Chagas-HIV; loop-mediated isothermal amplification; orally transmitted Chagas disease; primary infection after transplant in seropositive donor-seronegative recipients; real-time PCR; Trypanosoma cruzi
• Online Access: View Fulltext in Publisher

 A loop-mediated isothermal amplification assay was evaluated as a surrogate marker of treatment failure in Chagas disease (CD). A convenience series of 18 acute or reactivated CD patients who received anti-parasitic treatment with benznidazole was selected—namely, nine orally infected patients: three people living with HIV and CD reactivation, five chronic CD recipients with reactivation after organ transplantation and one seronegative recipient of a kidney and liver transplant from a CD donor. Fifty-four archival samples (venous blood treated with EDTA or guanidinium hydrochloride-EDTA buffer and cerebrospinal fluid) were extracted using a Spin-column manual kit and tested by T. cruzi Loopamp kit (Tc-LAMP, index test) and standardized real-time PCR (qPCR, comparator test). Of them, 23 samples were also extracted using a novel repurposed 3D printer designed for point-of-care DNA extraction (PrintrLab). The agreement between methods was estimated by Cohen’s kappa index and Bland–Altman plot analysis. The T. cruzi Loopamp kit was as sensitive as qPCR for detecting parasite DNA in samples with parasite loads higher than 0.5 parasite equivalents/mL and infected with different discrete typing units. The agreement between qPCR and Tc-LAMP (Spin-column) or Tc-LAMP (PrintrLab) was excellent, with a mean difference of 0.02 [CI = −0.58–0.62] and −0.04 [CI = −0.45–0.37] and a Cohen’s kappa coefficient of 0.78 [CI = 0.60–0.96] and 0.90 [CI = 0.71 to 1.00], respectively. These findings encourage prospective field studies to validate the use of LAMP as a surrogate marker of treatment failure in CD. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.